Mutation order shapes tumor aggression in mouse bowel organoids
Cancer does not arise from a single genetic change but from a sequence of mutations. New research using mouse bowel organoids shows that the order in which those mutations occur shapes how aggressive a tumor becomes.
Colorectal cancer is one of the best-studied cancers in terms of its genetic causes. Three genes play a central role: Kras, Apc, and Trp53. Researchers used mouse intestinal organoids, lab-grown mini-gut structures, to systematically vary the order in which these mutations were introduced.
Order of mutations matters in mice
The study, published in eLife, found that all mutation combinations promoted cell growth, both in the lab dish and in living mice. But one pattern stood out. Organoids in which Trp53 loss occurred before Apc inactivation showed reduced tumor-forming potential in mice with a functional immune system. In mice without a working immune system, this difference disappeared.
This suggests that mutation order influences how a tumor is recognized by the immune system. Organoids with Trp53 loss first appeared to have distinct immunological properties that made them less able to evade immune detection.
What this means for cancer research
These findings matter for understanding how early-stage colorectal cancer develops. In patients, reconstructing the precise order of mutations is difficult because cancer is usually detected at an advanced stage. Controlled mouse organoid models offer a way to study those early transitions.
The researchers note their findings may hold clinical relevance but that further studies are needed. The work was conducted using mouse organoids; whether the same principles apply to human colorectal cancer was not tested in this study.
Want to research this yourself?
Search for example:
- mutation order colorectal carcinogenesis
- tumor initiation immune evasion
- oncogenic driver mutations bowel cancer